Heska Corporation (NASDAQ: HSKA) seeks to enhance shareholder value through exceptional business practices and operational performance, strong governance, responsible reporting, and effective communication and engagement. Heska actively engages the public market with timely reporting, relevant presentations and events, and other important financial data and filings.
Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production under third-party agreements and channels, primarily for herd animal health.
- J.P. Morgan Healthcare Conference Presentation39th Annual J.P. Morgan Healthcare Conference (January 13, 2021 2:00 PM ET)
- Heska Corporation Third Quarter 2020 Earnings Call WebcastHeska Corporation Third Quarter 2020 Earnings Call Webcast (November 5, 2020 11:00 AM ET)
- Heska 2020 Investor DayHeska 2020 Investor Day Wednesday, November 18, 2020 from 9:00… (November 18, 2020 11:00 AM ET)
- Heska Corporation Second Quarter 2020 Earnings Call WebcastHeska Second Quarter 2020 Earnings Call Webcast (August 4, 2020 11:00 AM ET)
- Heska Corporation First Quarter 2020 Earnings Call Webcast (May 7, 2020 11:00 AM ET)
Please fill out the form below to receive company press releases and other information via email when they occur.